Evidence map›Paper›PMID 30298429›Full record

ArticleJournal of materials science. Materials in medicine2018

Novel osteoconductive β-tricalcium phosphate/poly(L-lactide-co-e-caprolactone) scaffold for bone regeneration: a study in a rabbit calvarial defect.

Hanna Pihlman, Pauli Keränen, Kaarlo Paakinaho, Jere Linden, Markus Hannula, Iida-Kaisa Manninen, Jari Hyttinen, Mikko Manninen, Outi Laitinen-Vapaavuori

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hanna PihlmanFaculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland. hanna.pihlman@helsinki.fi.ORCID http://orcid.org/0000-0002-6343-9585
Pauli KeränenFaculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
Kaarlo PaakinahoFaculty of Medicine and Life Sciences, Biomeditech, University of Tampere, Tampere, Finland.
Jere LindenFaculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
Markus HannulaFaculty of Biomedical Science and Engineering, Tampere University of Technology, Tampere, Finland.
Iida-Kaisa ManninenMuonio Health Center, Muonio, Finland.
Jari HyttinenFaculty of Medicine and Life Sciences, Biomeditech, University of Tampere, Tampere, Finland.
Mikko ManninenOrton Orthopaedic Hospital, Helsinki, Finland.
Outi Laitinen-VapaavuoriFaculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.

Funding

Finnish Veterinary Foundation -Suomen Eläinlääketieteen Säätiö -Tekes 40326/13
6 · The paper itself

Abstract

The advantages of synthetic bone graft substitutes over autogenous bone grafts include abundant graft volume, lack of complications related to the graft harvesting, and shorter operation and recovery times for the patient. We studied a new synthetic supercritical CO

Indexed as

AnimalsBiomechanical PhenomenaBone RegenerationBone SubstitutesBone TransplantationCalcium PhosphatesFemaleMaterials TestingOsteogenesisPolyestersPorosityRabbitsSkullSurface PropertiesTissue Scaffoldsbeta-tricalcium phosphateBone SubstitutesCalcium Phosphateslactide-caprolactone copolymerPolyesters

Identifiers

PMID30298429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.